英国中轴型脊柱关节炎延迟诊断的经济负担是什么
本研究构建马尔可夫经济模型,从英国国家医疗服务体系和社会视角估算中轴型脊柱关节炎延迟诊断的年度成本。模拟1000例患者、平均诊断延迟8.5年时,人均累积成本为193512英镑(95%CI:108770-306789),以生产力损失(65.1%)和自付费用(31.3%)为主。
要点
- 模拟1000例患者、平均诊断延迟8.5年时,人均累积成本为193512英镑(95%CI:108770-306789)。
- 成本以生产力损失(65.1%)和自付费用(31.3%)为主。
核心结论
- 中轴型脊柱关节炎延迟诊断因生产力损失给社会带来高成本。
- 早期诊断和治疗可能给患者带来显著获益,并可能减少生产力损失;但未来需研究评估长期健康经济影响。
研究设计与样本
- 本研究构建马尔可夫经济模型,从英国国家医疗服务体系和社会视角估算中轴型脊柱关节炎延迟诊断的成本。
- 模型参数来源于2016年国家中轴型脊柱关节炎协会患者调查、匿名患者个体数据、已发表文献和专家意见。
- 目标人群为文献定义的混合队列(64%为男性)、假定患有中轴型脊柱关节炎、症状起病年龄26岁。
- 进行了基础案例和概率敏感性分析以评估结果稳健性。
主要发现
- 在模拟1000例患者、平均诊断时间8.5年的队列中,每例中轴型脊柱关节炎患者延迟诊断的累积成本估计为193512英镑(95%CI:108770-306789)。
- 成本以生产力损失(65.1%)和自付费用(31.3%)为主。
局限性
- 未来需研究评估长期健康经济影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to develop an economic model to determine the annual cost of delayed axial SpA diagnosis in the UK, adopting both National Health Service (NHS) and societal perspectives. METHODS: We developed a Markov economic model to estimate the costs of delayed axial SpA diagnosis in the UK. Model parameters were sourced from a 2016 National Axial Spondyloarthritis Society patient survey, anonymized patient-level data, the published literature, and expert opinion. A literature-defined, mixed cohort (64% male) of people assumed to have axial SpA, whose age at symptom onset was 26 years, were targeted. To assess the robustness of the results, base case and probabilistic sensitivity analyses were performed. RESULTS: In a simulated cohort of 1000 patients, with a mean time to diagnosis of 8.5 years, we estimate the cumulative costs of delayed diagnosis per person living with axial SpA to be £193 512 (95% CI: 108 770-306 789). The costs were led by productivity losses (65.1%) and out-of-pocket expenses (31.3%). The total annual cost resulting from delayed axial SpA diagnosis in the UK has been estimated at £3.1 billion and £12.5 billion, based on a prevalence of 0.3% (Assessment of SpondyloArthritis international Society classification criteria) and 1.2% (European Spondyloarthropathy Study Group classification criteria), respectively. CONCLUSION: Delayed axial SpA diagnosis carries high costs for society due to productivity losses. Early diagnosis and treatment could offer significant benefits to the patient and potentially reduce productivity losses; however, future research is needed to evaluate the long-term health economic impact.
引用
- Zanghelini F, Xydopoulos G, Howard Wilsher S, et al. What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK? Rheumatology (Oxford). 2025. PMID: 40279291. doi:10.1093/rheumatology/keaf226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。